ESC Medical completes acquisition of Luxar:
This article was originally published in Clinica
Executive Summary
Now that ESC Medical has completed its acquisition of Luxar, a manufacturer of surgical and cosmetic lasers, Luxar will operate as a subsidiary of ESC. As part of the deal, ESC is to issue 2.5 million shares of its common stock. ESC develops and manufactures medical devices that incorporate lasers and intense pulse light source technology for non-invasive treatment of vascular lesions.